Molly Burich MS

Molly Burich is a Senior Manager, Government Affairs – Reimbursement and Policy for Otsuka America Pharmaceuticals. In her role she focuses on reimbursement and policy considerations associated with existing and pipeline products for Otsuka. Ms. Burich focuses on implementation of reimbursement and policy strategies to ensure patient access to products. Additionally, Ms. Burich is focused on the implementation of healthcare reform and health policy strategies as they relate specifically to patient access and reimbursement. Prior to this role, Ms. Burich focused on strategic and operational considerations associated with reimbursement, patient access and patient hub programs within Otsuka America Pharma.

Prior to joining Otsuka, Ms. Burich was an Assistant Director for Xcenda, an AmerisourceBergen Consulting Services company based in North Carolina. At Xcenda, Ms. Burich focused on reimbursement and health policy issues as they related to strategic reimbursement planning. Ms. Burich worked in collaboration with reimbursement, brand and managed markets teams across a variety of pharmaceutical and biotechnology clients across numerous disease states including, multiple sclerosis, hemophilia, oncology, mental health and rheumatoid arthritis. Prior to joining Xcenda, Ms. Burich worked for Avalere Health, a health care policy consulting firm based in Washington, DC. In that role, Ms. Burich specialized in reimbursement strategy and product commercialization for new pharmaceuticals and biotechnologies. In addition, she closely monitored ongoing legislative and regulatory changes for pharmaceutical, biotechnology, and medical device companies. Ms. Burich received a master of science in public service management with an emphasis in public policy from DePaul University and a bachelor of arts in political science from the University of Northern Colorado.